福瑞股份（300049）8月11日主力资金净流出1329.15万元

Group 1 - The core viewpoint of the news is that Furu Pharmaceutical (福瑞股份) has shown a slight increase in stock price, but the company is experiencing a decline in net profit and net profit after deducting non-recurring gains and losses in its latest financial report [1] - As of August 11, 2025, Furu Pharmaceutical's stock closed at 48.9 yuan, with a trading volume of 91,500 lots and a transaction amount of 451 million yuan [1] - The company's latest quarterly report indicates total operating revenue of 330 million yuan, a year-on-year increase of 2.35%, while net profit attributable to shareholders decreased by 32.97% to 28.64 million yuan [1] Group 2 - Furu Pharmaceutical has invested in 23 companies and participated in 552 bidding projects, indicating active engagement in business expansion [2] - The company holds 31 trademark registrations and 11 patents, showcasing its commitment to intellectual property [2] - Furu Pharmaceutical has obtained 17 administrative licenses, reflecting its compliance with regulatory requirements [2]